CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common Shares, par value (euro)0.12 per share
Symbol
CVAC on Nasdaq
Shares outstanding
22,421,536
Price per share
$4.52
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
19,565,943
Total reported value
$105,427,908
% of total 13F portfolios
0%
Share change
+7,970,401
Value change
+$42,942,070
Number of holders
92
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 92 institutional investors reported holding 19,565,943 shares of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC). This represents 87% of the company’s total 22,421,536 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) together control 78% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
GLAZER CAPITAL, LLC 20% 4,546,634 +664% 0.82% $24,506,000
ALPINE ASSOCIATES MANAGEMENT INC. 10% 2,295,422 +16% 0.75% $12,372,325
Qube Research & Technologies Ltd 7.6% 1,712,737 +45% 0.01% $9,231,652
BlackRock, Inc. 4.5% 1,016,297 -1.4% 0% $5,477,841
AQR Arbitrage LLC 4.4% 991,688 +2146% 0.14% $5,345,198
WATER ISLAND CAPITAL LLC 3.4% 762,138 -20% 0.59% $4,107,924
Magnetar Financial LLC 2.9% 654,796 0.02% $3,529,350
ROYAL BANK OF CANADA 2.2% 501,610 +5107% 0% $2,703,000
Bridgewater Associates, LP 2.1% 466,407 0.01% $2,513,934
BANK OF AMERICA CORP /DE/ 2% 443,324 +364% 0% $2,389,516
UBS Group AG 1.8% 401,269 +66% 0% $2,162,840
GOLDMAN SACHS GROUP INC 1.8% 399,893 -7.8% 0% $2,155,423
NORTHERN TRUST CORP 1.6% 354,694 -9.5% 0% $1,911,800
BNP PARIBAS FINANCIAL MARKETS 1.5% 330,515 0% 0% $1,781,476
JPMORGAN CHASE & CO 1.3% 301,521 -4% 0% $1,625,199
CSS LLC/IL 1.2% 273,495 0.09% $1,474,138
NEW YORK LIFE INVESTMENT MANAGEMENT LLC 1.2% 258,116 0.01% $1,391,245
DEUTSCHE BANK AG\ 1.1% 255,783 +19% 0% $1,378,671
Carmignac Gestion 1% 235,180 +172% 0.02% $1,267,620
GEODE CAPITAL MANAGEMENT, LLC 1% 226,497 -8% 0% $1,220,818
CITIGROUP INC 0.97% 216,875 +352% 0% $1,168,957
MORGAN STANLEY 0.93% 207,696 +73% 0% $1,119,480
Swiss National Bank 0.86% 193,579 0% 0% $1,034,787
Amundi 0.82% 183,856 +34% 0% $994,661
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.67% 150,428 0% $810,286

Institutional Holders of CureVac N.V. - Common Shares, par value (euro)0.12 per share (CVAC) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 55,866 $252,080 -$8,705 $4.52 3
2025 Q3 19,565,943 $105,427,908 +$42,942,070 $5.39 92
2025 Q2 11,518,489 $62,489,985 +$21,427,791 $5.43 89
2025 Q1 7,872,317 $21,841,913 -$777,544 $2.77 81
2024 Q4 7,856,016 $26,624,069 -$5,834,095 $3.41 74
2024 Q3 11,129,274 $32,809,235 -$7,062,642 $2.94 78
2024 Q2 14,136,665 $47,963,107 +$6,606,676 $3.40 84
2024 Q1 2,029,355 $6,148,968 -$21,297,851 $3.03 9
2023 Q4 257,246 $1,083,006 +$451,506 $4.21 2
2023 Q3 33,184,691 $226,495,738 -$14,845,657 $6.83 82
2023 Q2 35,207,405 $366,982,750 -$7,762,695 $10.42 84
2023 Q1 36,701,197 $255,777,503 +$175,801,081 $6.97 81
2022 Q4 11,605,942 $70,001,654 +$25,580,086 $6.03 78
2022 Q3 7,035,465 $55,518,292 -$14,556,247 $7.88 69
2022 Q2 8,362,037 $113,224,160 -$93,430,132 $13.61 74
2022 Q1 14,444,405 $283,157,200 -$10,021,703 $19.61 102
2021 Q4 14,649,709 $503,022,059 +$23,340,307 $34.31 99
2021 Q3 13,708,179 $748,775,928 -$12,682,598 $54.62 103
2021 Q2 10,741,990 $789,185,787 -$28,402,611 $73.48 102
2021 Q1 14,053,243 $1,284,955,152 +$337,541,447 $91.46 83
2020 Q4 7,249,042 $588,213,325 -$18,568,618 $81.07 57
2020 Q3 7,605,083 $355,419,000 +$354,349,010 $46.55 42
2020 Q2 108 $8,000 $0 $74.07 1
2020 Q1 108 $8,000 $0 $74.07 1
2019 Q4 108 $8,000 $0 $74.07 1
2019 Q3 108 $8,000 $0 $74.07 1
2019 Q2 108 $8,000 $0 $74.07 1
2019 Q1 108 $8,000 $0 $74.07 1